Clinical Trials Directory

Trials / Completed

CompletedNCT03391492

Invasive Pulmonary Aspergillosis Complicating Influenza Infection

Invasive Pulmonary Aspergillosis Complicating Influenza Infection in Critically Ill Patients: a Prospective, Observational, Multicenter Case Control Registration Study

Status
Completed
Phase
Study type
Observational
Enrollment
298 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study the incidence and outcome of invasive pulmonary aspergillosis (IPA) in ICU patients with severe influenza and in influenza-negative control patients with severe community-acquired pneumonia

Detailed description

This prospective multicentre case-control registration study in Dutch and Belgian ICUs will assess the difference in incidence and outcome of invasive pulmonary aspergillosis (IPA) in ICU patients with severe influenza compared with influenza-negative control patients with severe community-acquired pneumonia during the coming three influenza seasons (2017-2020). The study will further assess the differences in clinical characteristics and risk factors between influenza patients with and without invasive aspergillosis. All consecutive patients aged 18 or older admitted to ICU during the inclusion period with respiratory distress due to influenza positive/negative community acquired pneumonia (CAP) will be included.

Conditions

Timeline

Start date
2018-01-20
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2018-01-05
Last updated
2021-07-30

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03391492. Inclusion in this directory is not an endorsement.